On the 1st, Samsung Bioepis revealed its plans to introduce "Obodence," a new therapy for ...

Novo Reaches $32 Million Settlement to Resolve Ozempic-Related Legal Dispute

China introduces its inaugural weight loss medication as the emerging market is set for swift expansion.

Chinese-developed obesity medications may drive the next generation of therapies - Nature

Are Indian Firms Capable of Competing with Multinational Corporations in GLP-1 Manufacturing? - BioSpectrum India